Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.67 NOK | -0.68% | -3.10% | -31.45% |
06-20 | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting | CI |
06-11 | Nykode Therapeutics ASA Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy | CI |
Chart calendar Nykode Therapeutics
Upcoming events on Nykode Therapeutics
Past events on Nykode Therapeutics
2024-05-15 | Annual General Meeting |
2024-05-14 10:00 | Q1 2024 Earnings Call |
2024-05-14 01:00 | Q1 2024 Earnings Release |
2024-02-28 10:00 | Q4 2023 Earnings Call |
2024-02-28 01:00 | Q4 2023 Earnings Release |
2024-01-10 18:45 | J.P. Morgan Healthcare Conference |
2023-11-15 10:00 | Q3 2023 Earnings Call |
2023-11-15 04:30 | Q3 2023 Earnings Release |
2023-10-12 10:00 | MRNA Cancer Vaccines Summit |
2023-09-11 | H.C. Wainwright Global Investment Conference |
2023-08-23 09:00 | Q2 2023 Earnings Call |
2023-08-23 00:45 | Q2 2023 Earnings Release |
2023-06-07 10:00 | Jefferies Global Healthcare Conference |
2023-05-30 00:00 | ABGSC Life Science Summit |
2023-05-12 04:01 | Q1 2023 Earnings Call |
2023-05-12 01:00 | Q1 2023 Earnings Release |
2023-05-11 04:00 | Annual General Meeting |
2023-04-19 10:00 | VB-C-02 Phase 2 Trail Results Call |
2023-02-28 10:00 | Q4 2022 Earnings Call |
2023-02-28 01:00 | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 12,4 12,0 3.72% | 0,00 | 314 366 -14.34% | 93,3 55,6 67.79% | 141 122 15.74% | 140 |
EBITDA Million NOK | Released Forecast Spread | -98,8 -85,0 -16.18% | 0,00 | -87,9 10,6 -929.18% | -543 -505 -7.36% | -593 -621 4.51% | -695 |
EBIT Million NOK | Released Forecast Spread | -98,9 -85,0 -16.34% | 0,00 | -94,4 10,6 -990.13% | -549 -564 2.62% | -615 -650 5.32% | -721 |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -96,0 -83,0 -15.61% | 0,00 | -97,4 4,79 -2131.68% | -527 -543 3% | -467 -590 20.89% | -669 |
Net income Million NOK | Released Forecast Spread | 0,00 0,00 - | 1 249 | -82,3 4,79 -1817.89% | -442 -447 1.23% | -372 -521 28.59% | -614 |
EPS NOK | Released Forecast Spread | -0,35 -0,31 -13.34% | 4,25 | -0,26 0,01 -5354.6% | -1,55 -1,55 -0.33% | -1,27 -1,74 27.16% | -1,88 |
Announcement Date | 15/04/20 | 21/04/21 | 31/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 33,2 53,3 -37.71% | 13,0 105 -87.64% | 34,1 10,2 235.85% | 33,3 13,0 156.81% | 54,2 12,6 328.9% | 30,3 | 24,1 22,9 5.51% | 11,0 66,9 -83.57% | 40,4 | 44,3 | 44,3 |
EBITDA Million NOK | Released Forecast Spread | -94,9 -57,0 -66.49% | -197 -6,75 -2827.29% | -121 -164 25.92% | -148 -175 15.13% | -176 -167 -4.85% | -163 -157 -3.52% | -168 | -167 | -169 | ||
EBIT Million NOK | Released Forecast Spread | -99,4 -57,0 -74.31% | -202 -6,75 -2895.79% | -149 -141 -5.73% | -127 -169 24.74% | -154 -179 13.87% | -182 -173 -5.05% | -169 -164 -3.26% | -175 | -173 | -175 | |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -106 -57,0 -85.83% | -195 -6,75 -2789.08% | -127 -133 4.62% | -109 -161 32.5% | -134 -187 28.3% | -100 -172 41.85% | -178 -170 -4.76% | -159 | -159 | -163 | |
Net income Million NOK | Released Forecast Spread | -84,9 -57,0 -48.84% | -151 -6,75 -2140.86% | -126 -120 -5.11% | -97,9 -145 32.42% | -110 -187 40.83% | -56,5 -164 65.47% | -162 -170 4.82% | -152 | -152 | -156 | |
EPS NOK | Released Forecast Spread | -0,41 -0,41 0.16% | -0,32 -0,50 36.23% | -0,32 -0,64 49.77% | -0,21 -0,53 59.85% | -0,54 -0,53 -1.88% | -0,47 | -0,46 | -0,46 | |||
Announcement Date | 23/08/22 | 23/11/22 | 28/02/23 | 12/05/23 | 22/08/23 | 15/11/23 | 28/02/24 | 14/05/24 | - | - | - |
Past sector events for Nykode Therapeutics
2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VACC Stock
- Calendar Nykode Therapeutics